• We investigated the toxicity of the antiviral compound hydroxyacyclovir (9-[hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine, or BW-B759U), following intravitreal injection in the rabbit. Intravitreal doses of 10, 20, 40, 80, 100, 200, and 400 μg produced no discernible ophthalmoscopic or histologic changes. Intravitreal doses of 40, 200, and 400 μg produced no changes in the electroretinography B-waves. The low level of retinal toxicity and excellent median inhibitory dose values of intravitreal BW-B759U against cytomegalovirus suggest its potential therapeutic utility in the treatment of cytomegalovirus retinitis.
Pulido J, Peyman GA, Lesar T, Vernot J. Intravitreal Toxicity of Hydroxyacyclovir (BW-B759U), a New Antiviral Agent. Arch Ophthalmol. 1985;103(6):840–841. doi:10.1001/archopht.1985.01050060100036
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: